Covid-19: DCGI approves phase 2, 3 clinical trials of Covaxin on children aged 2 to 18 years | India News
Kolkata: A medic shows a vial containing doses of Covaxin during a Covid-19 vaccination drive at a government hospital, in Kolkata. (PTI) NEW DELHI: The Drugs Controller General of India (DCGI) approved phase 2 and 3 clinical trial of Bharat Biotech's Covaxin vaccine in the age group of 2 to 18 years, the ministry of health and family welfare informed on Thursday. "The National Regulator of the country, the Drugs Controller General of India (DCGI), after careful examination, has accepted the recommendation of Subject Expert Committee (SEC) and accorded permission to conduct the Phase II/III ...